Tag Archives: anti-inflammatory

February, 2017

  • 15 February

    X-Chem Expands its Collaboration with Janssen in Inflammatory Diseases

    WALTHAM, Mass.–(BUSINESS WIRE)–X-Chem, Inc. (X-Chem) announced today that it has expanded its collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover new drug leads for the treatment of inflammatory disease. The multi-target expansion builds on the parties’ existing discovery and license partnership, …

May, 2016

  • 16 May

    Pfizer to Purchase Anacor in $5.2 Billion Deal

    Pfizer Inc. (NYSE:PFE) and Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of cash, of approximately $5.2 billion, which assumes the conversion of Anacor’s …

December, 2015